Tg2576 mice show high levels of human APP protein with Swedish Mutation during prodromal and early symptomatic stages. Interestingly, this is strictly associated with unbalanced expression of its two RNA binding proteins (RBPs) regulators, the Fragile-X Mental Retardation Protein (FMRP) and the heteronuclear Ribonucleoprotein C (hnRNP C).
INTRODUCTION
Overexpression of the amyloid precursor protein (APP) is a common feature of several intellectually disabling pathologies including Alzheimer's Disease (Tcw and Goate, 2017) , Down syndrome (Head et al, 2018) and autism spectrum disorders (Sokol et al., 2006 , Ray et al., 2011 Westmark, 2019 , Westmark et al., 2016 . In Alzheimer's Disease (AD), despite the observation of a direct link between increased levels of full length APP and elevated βamyloid peptide (Aβ) production (Johnston et al., 1994) , APP-related research has prevalently focused on the toxic role of its cleavage products. Evidence that functional changes occur in the brain long before the onset of cognitive deficits (Beason-Held et al, 2013 , Pignataro et al., 2019 has, however, highlighted the need to identify increasingly earlier AD brain markers. Within this context, the dysregulation of APP levels upstream to its pathogenic proteolytic cleavage is gaining an increased interest (Zhu et al., 2019) . Nevertheless, although epigenetic (Maloney an Lahiri, 2016) and posttranscriptional (Long et al., 2012) factors have been suggested to play a role in early -life APP regulation, the translational mechanisms which regulate APP expression at p rodromal and early symptomatic stages of the disease remain largely unexplored.
In mouse models of familiar AD, overexpression of mutant forms of the human amyloid precursor protein (hAPP) promotes formation of toxic Aβ and impairs cognition at age points which vary according to the locus of the mutation in the APP gene and the number of hAPP transgene copies (Howlett et al., 2009) . For example, Tg2576 mice carrying the Swedish KM670/671N mutation are cognitively intact at 2 months of age (D'Amelio et al., 2011) . Then, cognition Pharmacological inhibition of elF2α (eukaryotic translation initiation factor 2 subunit alpha) dephosphorylation was carried out by injecting salubrinal (Tocris Cat. No. 2347 ) emulsified in DMSO (Sigma) (1% diluted in saline). Two administration routes were used according to previously established injection protocols (Sokka AL et al., 2007) . Mice were given either one intra-cerebro-ventricular (i.c.v.) injection (1 μl of a 75 μM solution) or one daily intraperitoneal (i.p.) injection repeated for 7 consecutive days (1 mg/kg). Control mice received i.c.v or i.p. injections of DMSO.
Western blot determination of APP, Aβ and BACE-1 levels in hippocampal extracts
Hippocampi of WT and Tg2576 mice, treated with salubrinal or DMSO, were lysed with RIPA buffer (10 mM Tris -HCl, pH 7.5, 150 mM NaCl, 2% Nonidet P-40, 5 mM EDTA, 0.1 mM phenylmethylsulfonyl fluoride, 1 mM βglycerophosphate, 1 mM sodium orthovanadate, 10 mM sodium fluoride, 0.1 M SDS, 1% protease inhibitor cocktail-(Sigma Aldrich, see Borreca et al., 2016) . After homogenization, samples were centrifuged at 12000 g for 10 minutes and the supernatant was collected, quantified with Bradford assay, and 50 µg of total protein were loaded on 12% acrylamide gel for determination of APP (Sigma), Amyloid-βAβ peptide species (D54D2 Cell Signaling), β-secretase enzyme-1 (BACE-1, Millipore)
Western blot for determination of Caspase-3 activity in hippocampal synaptosomes
Hippocampi of WT and Tg2576 mice treated with salubrinal or DMSO were lysed with Homogenization buffer (320 mM sucrose, 4 mM Hepes pH 7.4, 1mM EGTA, 1 mM PMSF and 1x protease inhibitor cocktail). The homogenized tissue was centrifuged at 1000g for 10 minutes a 4°C. the supernatant was collected and centrifuged at 12000g for 15 minutes at 4°C. The obtained pellet was resuspended in homogenization buffer and centrifuge at 13000g fo r 15 minutes at 4°C. The pellet was resuspended in RIPA buffer (10 mM Tris -HCl, pH 7.5, 150 mM NaCl, 2% Nonidet P-40, 5 mM EDTA, 0.1 mM phenylmethylsulfonyl fluoride, 1 mM β-glycerophosphate, 1 mM sodium orthovanadate, 10 mM sodium fluoride, 0.1 M SDS, 1x protease inhibitor cocktail-Sigma Aldrich). The resuspended pellets was sonicated and centrifuged at 12000 rpm for 10 minutes at 4°C. The synaptosomes were loaded on acrylammide gel and the CASP3 (Cell signaling) levels (cleaved/total, D'Amelio et al., 2011) was evaluated. The primers and second antibodies used in this experiment are listed in Table 1. electrode (FHC Inc.; Bowdoin, ME) and a CSF-filled borosilicate glass recording electrode that were positioned in the stratum radiatum of the CA1 hippocampal region at a distance of 200-300 μm. All experiments were performed at the intensity yielding a half-maximal response of input-output curves that was obtained by measuring the fEPSP initial slope at increasing 10 µA steps of afferent stimulation (D'Amelio et al., 2011) .
Long Term Depression
LTD was induced 20 min after the test stimulation (at half-maximal intensity, every 30 s) when fEPSP slope stability was obtained. The slice was challenged with DHPG (50 M) for 10 min and then washed out for 60 min. The DHPG-LTD was evaluated by the fEPSP mean slope 55-60 min from DHPG washout, normalized to the mean slope during baseline, and recorded during the 10 min preceding DHPG perfusion. The field responses were re corded with a MultiClamp 700B amplifier and digitized with Digidata 1322A. Data were sampled at 20 kHz. Traces were obtained by pClamp 9.2 and analyzed using Clampfit 9.2 (all from Molecular Devices; Sunnyvale, CA).
Golgi staining
After one week of pharmacological treatment with salubrinal or DMSO, mice were deeply anaesthetized with a cocktail of Zoletil (800mg/kg) and Rompum (200mg/kg) and perfused transcardially with 0.9% saline solution (N = 7 mice per group). Brains were dissected and immediately immersed in a Golgi-Cox solution (1% potassium dichromate, 1% mercuric chloride, and 0.8% potassium chromate) at room temperature for 6 days according to a previously described protocol (Gibb R et al., 1998) . On the seventh day, brains were transferred in a 30% sucrose solution for cryoprotection and then sectioned with a vibratome. Coronal sections (100 μm) were collected and stained according to the method described by Gibb and Kolb (1998) . Sections were stained through consecutive steps in water (1 minute), ammonium hydroxide (30 minutes), water (1 minute), developer solution (Kodak fix 100%, 30 minutes), and water (1 minute).
Sections were then dehydrated through successive steps in alcohol at rising concentrations (50%, 75%, 95%, and 100%) before being closed with slide cover slips. Spine density was analyzed on CA1 neurons. Neurons were identified with a light microscope (Leica DMLB) under low magnification (20×/NA 0.5). Five neurons within each hemisphere were taken from each animal. On each neuron, five 30-100 μm dendritic segments of secondary and tertiary branch order of CA1 dendrites were randomly selected and counted using Neurolucida software. Only protrusions with a clear connection of the head of the spine to the shaft of the dendrite were counted as spines. Statistical comparisons were made on single neuron values obtained by averaging the number of spines counted on segments of the same neuron.
The analysis was conducted by an experimenter blind to the experimental condition.
Novel object recognition
The novel object recognition (NOR) test was carried out in 3-month old Tg2576 and WT mice. Testing started on the day after mice received the last i.p. injections of salubrinal or DMSO. Mice in their home cage were transferred to experimental room and left to acclimate for 1 h to the new environment. NOR testing consisted in three sessions ( Figure   5A ). On the first session (open field exploration), each mouse was placed in an empty squared open field (40 cm in side) surrounded by 60 cm-high walls and left free to explore it for 10 minutes. The mouse was returned to its home cage for a 10-min pause during which two identical glass cylinders of 3 cm in diameter and 10 cm in height (object on the left: sx; object on the right: dx) were put in opposite corners of the open field. On the second session (training), the mouse was placed in the center of the open field and allowed to explore objects sx and dx for 10 minutes. The mouse was returned again to its home cage for a 1 h-pause during which one (s x or dx) familiar object (FO) was substituted with a novel object (NO), a multicolored kubrik cube of 5 cm in side (NO). On the third session (testing), the mouse J o u r n a l P r e -p r o o f Journal Pre-proof was placed again the center of the open field and allowed to explore the FO and the NO for 10 min. Object exploration was defined as mice sniffing or touching the object with its nose and/or forepaws. The objects were cleaned with 10% ethanol between each session. The preference index was calculated according the formula previously described (Antunes et al., 2012) which estimates the percentage of time spent exploring each object (FO or NO) over the total time spent exploring both objects. A preference index above 50% indicates a preference for the NO, below 50% a preference for the FO, and 50% no preference.
NOR-induced c-fos activation
1 h following NOR testing, mice were deeply anesthetized with mix solution of ketamina/xylazin (100 mg/kg) and immediately perfused with PAF 4% according to a procedure previously described (Borreca et al., 2018) . The brains were immediately removed, post-fixed in PAF 4% overnight, transferred in sucrose (30% diluted in PBS1X), and then sectioned coronally with a cryostat (40 μm). Slices were immediately washed with PBS 1X and incubated with primary antibody (c-fos 1:400) diluted in a solution of PBS 1X and 0.3% Triton overnight at 4°C. After incubation, the slices were immediately washed with PBS 1X and incubated with specific secondary antibody (Alexa Fuor 555 antirabbit) for two hours at room temperature avoiding light. DAPI staining (1:1000, Enzo Life Science) was performed at the last wash with PBS 1X. Sections were mounted with fluoromount (Sigma) and coverslipped. The staining was visualized at confocal microscope (Zeiss LSM700; magnification 20X) and images were analyzed with IMARIS software. The number of c-fos immunoreactive spots in the CA1 hippocampus were counted in 10 areas of 25x25 µm were analyzed avoiding the DAPI. Number of spots for WT and Tg2576 mice were counted compared between groups.
Statistical analyses
Group differences in hippocampal APP mRNA polysome gradient distribution and in p -eiF2α/eiF2α ratio were evaluated by means of two-way ANOVAs with genotype and age point as main factors. Student's t -tests (two-tailed) for unpaired samples were used to evaluate the effect of genotype on p-eIF4E/eIF4E and eIF4G levels, and the effect of the injection route (i.p. vs i.c.v.) on APP and Aβ levels in the hippocampus of 3-month old Tg2576 mice. In mice of the same age receiving i.p. DMSO or salubrinal injections, differences in hippocampal levels of p-eIF2α, APP, BACE-1, in the cCASP-3/Casp-3 ratio measured in hippocampal synaptosomes, and in dendritic spines, LTD, and NOR-induced c-A reliable way to assess mRNA translational efficiency is to analyze its partitioning between actively translating polysomes and mRNPs that are not translated. Total RNA was extracted from the gradient fractions and then analyzed by quantitative RT-PCR for hAPP mRNAs. Data are shown in Figure1B and are expressed as density levels of mRNA in polysomal vs non polysomal fraction (pool of four mice from each genotype reproduced three times). A two-way ANOVA performed on these data revealed a significant genotype x age interaction (F (2,12) = 326,42; p < 0,001). Post hoc pair comparisons showed that hAPP mRNA was significantly more localized in the polysomal fraction when Tg2576 mice were 1-month (p < 0.01) and 3-month (p < 0 01) old, but equally distributed in polysomal and non polysomal fractions when mice were 6-month old (p = 0.75), the latter observation being in line with data obtained in 9month old mice bearing the triple APP/Tau/PS1 mutation (Caccamo et al., 2015) .Thus, the major presence of hAPP mRNA in polysomal fractions strictly associates with the upregulation of protein expression which occurs before or shortly after mice exhibit signs of cognitive deterioration. Of note, mouse APP (mAPP) was more localized on non polysomal fractions in both genotypes ( Supplementary Figure 1) .
Tg2576 mice show early upregulation and late downregulation of translation
The eukaryotic initiation factor-2α (eIF2α) is an essential factor for protein synthesis. Extensive evidence suggests that its aberrant phosphorylation induces synaptic failure and neurodegeneration through persistent inhibition of mRNA translation. In line with this hypothesis, Kim et al (2007) showed that p-eIF2α is upregulated in hippocampi homogenates from fully symptomatic 12-month-old Tg2576 mice. Interestingly, we confirm the p-eIF2α upregulation in hippocampal extracts from 6-and 9-month old symptomatic mice, but provide evidence of its downregulation at earlier stages of development (Figure 2 A-B) . A two-way ANOVA performed on p-eIF2α levels measured in both genotypes at four age points revealed a significant genotype x age point interaction (F (3,16) = 77,40, p < 0.001). Post hoc pair comparisons then showed significant differences between genotypes at all age points which developed, however, in opposite directions according to the age point. Specifically, p-eIF2α levels were lower in Tg2576 than in WT mice at 1 month (p < 0.03) and 3 months (p < 0.01) of age, but, consistent with previous data (Kim et al., 2007) , these levels were higher in Tg2576 than in WT mice at 6 months (p < 0.04) and 9 months (p < 0.02) of age, These findings were confirmed by immunofluorescence detection of eIF2α phosphorylation expression in hippocampal sections taken from Tg2576 and WT mice at the same age points ( Figure 2C ). Of note, the non-phosphorylated form of eIF2α did not vary between genotypes when mice were examined at 1 month (p = 0.79) and 3 months ( p =0.18) of age, but was decreased in mutant mice compared to WT mice at 6 months (p < 0.04) and the 9 months (p = 0.05) age concurrently with the increase in the phosphorylated form. Altogether, these results reveal the existence of non-linear variations of peIF2α hippocampal levels in Tg2576 mice which are consistent with an early upregulation followed by a downregulation of the protein synthesis machinery. Total blot of p-eIF2 (A-B) are shown in Supplementary Figure 2 This factor is specifically involved in the mRNA-ribosome binding step of eukaryotic protein synthesis of capdependent translation so that the majority of cellular mRNA requires eIF4E to be translated into proteins (Richter JD et al., 2005) . In the 48S initiation complex, a role for the eIF4G subunit of eIF4F has also been documented (Grüner S et al., 2016) . Specifically, eIF4G is a scaffold protein that binds eIF4E and serves as a central ribosome adaptor module which attracts 40S ribosomal subunits to the 5′ end of mRNAs via direct association with eIF3. We therefore measured the hippocampal levels of the phosphorylated and non-phosphorylated forms of eIF4E, and the levels of eIF4G in J o u r n a l P r e -p r o o f Journal Pre-proof hippocampal extracts from 3-month old Tg2576 mice. Results ( Figure 2D -E) showed that none of these pre-initiation component of translation was altered in this genotype x age condition (p-eIF4E/eIF4E: t (9) = 0,47, p = 0,65; eIF4G: t (4) = 0,94, p = 0,40). Total blots for eIF4E (D), eIF4G (E) are shown in Supplementary Figure 2 .
Salubrinal reduces hippocampal APP and Aβ species levels
Salubrinal is a selective inhibitor of cellular complexes that dephosphorylate eIF2α and therefore decreases overall translation. Having shown that APP and Aβ levels are increased at ages where p-eIF2α phosphorylation is reduced, we The verification that salubrinal rescues early upregulation of translation requires to show that the compound increases p-eIF2α levels of Tg2576 mice up to the levels of WT mice. Results are shown in Figure 3C . Statistical comparisons showed a main effect of genotype (F (1,10) = 9,93; p <0.01), of treatment (F (1,10) = 15,77; p <0.001) and of the genotype x treatment interaction (F (1,10) = 5,21; p <0.05). Post hoc comparisons first confirmed our previous observation in nontreated mice (see Figure 2 ) that p-eIF2α levels in the DMSO condition are significantly lower in Tg2576 mice than in WT mice (p < 0.05). As shown in Figure 3C , salubrinal increased p-eIF2α in both genotypes (salubrinal vs DMSO WT mice, p < 0.001; salubrinal vs DMSO Tg2576 mice, p < 0.05). Remarkably, eIF2α levels were similar in salubrinal Tg2576 and DMSO WT mice (p > 1 ). For APP ( Figure 3D ), we found a significant genotype x treatment interaction (F (1,5) = 27.73; p < 0.01). In the DMSO condition, APP levels were higher in Tg2576 mice than in WT mice ( p < 0.05).
Salubrinal decreased APP in the mutant mice (DMSO vs salubrinal Tg2576 mice, p < 0,01) to the level of DMSOinjected mice (salubrinal Tg2576 mice vs DMSO WT mice, p = 0.27). BACE1 is the first cleaving enzyme in the APP amyloid pathway. Extensive evidence show that BACE-1 inhibitors decrease Aβ load and reduce neuro-inflammation in fully symptomatic transgenic AD mice (Neumann et al., 2015) . Differently, mixed effects were reported in AD patients especially when these inhibitors were administered peripherally (Georgievska et al., 2015) . Here we show that salubrinal treatment decreased and increased BACE-1 levels in Tg2576 mice and WT mice respectively ( Figure 3E) . A two-way ANOVA revealed a significant effect of genotype (F (1,7) = 6,15; p < 0.05) and genotype x treatment interaction (F (1,7) = 79,93, p < 0.01). Post hoc comparisons showed that BACE-1 levels were higher in DMSO Tg2576 than in DMSO WT mice (p < 0.03), but that the treatment was efficient in decreasing BACE-1 levels of Tg2576 mice to those of DMSO WT mice (p = 0.42). Total blots for p-eIF2 (C), APP (D) and BACE-1 (E) are shown in Supplementary 
Salubrinal rescues AD-selective caspase-3 alteration in hippocampal synaptosomes from early symptomatic

Tg2576 mice
Caspase-3 (Casp-3) activity is significantly increased at hippocampal synapses of Tg2576 mice where it causes permanent activation of calcineurin which leads to dephosphorylation of the AMPA receptor GluR1 subunit and its removal from postsynaptic sites (D'Amelio et al., 2011) . Because protein synthesis is required for Casp-3 activation (Coxon et al., 1998) , we examined the possibility that salubrinal-mediated decrease of eIF2α phosphorylation, which reduces protein translation, could normalize Casp-3 levels in the mutant mice. Results are shown in Figure 3F . In line with this hypothesis, statistical comparison of the cCasp-3/Casp-3 ratio measured in the four mice groups revealed a significant genotype x treatment interaction (F (1,8) = 1,13 p = 0.01). Pair comparisons then showed that these levels were reduced in salubrinal Tg2576 mice compared to DMSO Tg2576 mice (p = 0.01) and were not different from those detected in DMSO WT mice (p =0.99). To our knowledge, these data provide the first in vivo demonstration that, as in vitro (Gong et al., 2015) , salubrinal is efficient in decreasing apoptosis markers at hippocampal synapses. Total blots for Caspase-3 (F) are shown in Supplementary Figure 3 .
Effect of salubrinal in WT mice
Consistent with a previous report (Mouton-Liger et al., 2012) that increasing eIF2α phosphorylation in healthy mice augments BACE-1 levels and induces Aβ amyloidogenesis, higher levels of BACE-1 (p <0.01) ( Figure 3E ) and p-eIF2α (p < 0.01) ( Figure 3C ) were detected in WT mice treated with salubrinal compared to the WT mice treated with DMSO.
Salubrinal reverts synaptic plasticity alterations
At 3 months of age, Tg2576 mice show an increased magnitude of DHPG-induced long-term depression (LTD) at CA3-CA1 hippocampal synapses (D'Amelio et al, 2011) . We applied the same LTD induction protocol in acute hippocampal slices obtained from Tg2576 and WT mice treated with salubrinal or DMSO. The data are shown in Figure 4 A-C. A two-way ANOVA carried out on relative changes of fEPSP slopes before and after low frequency stimulation in DMSO-and salubrinal-injected Tg2576 ( Figure 4A ) and WT ( Figure 4B ) mice revealed a significant genotype x treatment interaction (F (1,35) = 16.87; p < 0.01). Pair comparisons of LTD percentage data ( Figure 4C ) showed that DMSO-injected Tg2576 mice exhibited a significant increase in the magnitude of CA3-to-CA1 LTD compared to DMSO-injected WT mice (p < 0.001) which was rescued by salubrinal treatment (salubrinal Tg2576 vs DMSO Tg2576 mice, p < 0.001; salubrinal Tg2576 mice vs DMSO WT mice, p > 1). Dendritic spines are among the first synaptic elements which are disrupted during AD-related cognitive decline (Scheff et al., 2007) . In Tg2576 mice, spine density in CA1 pyramidal neurons is significantly decreased at 3 months of age (D'Amelio M et al., 2011) . We measured spine density in Golgi-stained pyramidal CA1 neurons from Tg2576 and WT mice treated with salubrinal and DMSO.
Statistical comparison of spine density revealed a significant genotype x treatment interaction (F (1,10) = 27.37; p = 0.01). consecutive days and their performance in the novel object recognition (NOR) task was compared with the performance of wild-type (WT) mice injected with DMSO. Mice were first exposed to two identical objects (training) and, 1 h after, one of familiar object was substituted with a novel object (testing). The time spent exploring each object was recorded during each phase and the preference index for each object was calculated (time exploring one object div ided by the time exploring the two objects*100). 
